The U.S. Senate is considering legislation allowing Medicare to negotiate with drug companies. Sens. Hassan and Shaheen support this legislation and should be encouraged to continue to work for this bill. The U.S. pays about twice as much for health care and our drugs cost three times as much as the same drugs in other nations.
Allowing Medicare to negotiate drug prices will save Medicare and taxpayers a great deal of money. The nonpartisan CBO estimates this bill, already passed by the U.S. House would save nearly $300 billion over the next ten years. The VA has this ability and it is time to allow Medicare the same opportunity. It is time for the U.S. Senate to act.
Michael Cauble
Bedford